Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarechale Cap. Regulatory News (MAC)

Share Price Information for Marechale Cap. (MAC)

Share Price is delayed by 15 minutes
Get Live Data
6.00    -1.00 (-14.29%)
Bid:
5.50
Ask:
6.50
Spread: 1.00 (18.182%)
Market Cap: £15.44m
MAC Live PriceLast checked at - London Stock Exchange

Intraday Marechale Cap. Share Chart

Half-year Report

19 Dec 2024 16:30

Marechale Capital Plc - Half-year Report

Marechale Capital Plc - Half-year Report

PR Newswire

LONDON, United Kingdom, December 19

19 December 2024

Marechale Capital plc

("Marechale Capital", “Marechale” or the "Company")

Half-yearly Results

Marechale Capital plc, an established City of London based corporate finance house with a long-term track record and a strong reputation for advising and financing high growth consumer brands, leisure, clean energy, mineral extraction and technology companies, announces its unaudited half-yearly results for the six months ended 31 October 2024 (the “Period”).

Chairman’s Statement

Following the announcement with Marechale’s full year results released in August 2024, the market continues to remain challenging, particularly in the hospitality sector.

During the six months ended 31 October 2024, the Company generated gross profits of £103,468 (2023: £93,813) and delivered an operating loss of £138,485 (2023: loss of £155,421 ), resulting in an overall loss before tax of £178,261 (2023: loss of £155,803).

The Company’s balance sheet shows a net asset value of £3,183,537 (2023: £3,340,486 ), representing 3.01p (2023: 3.15p) of value per share in issue. The Company remains positive about the investments that it holds in its client companies.

Marechale Capital continues to see interesting corporate finance and advisory projects where it can take founders shares and warrants as part of its advisory fees. On a positive note, Marechale has completed transactions during the period for Weardale Lithium, Forest Road Brewery, Stubben Edge and Chestnut Inns. However, the market remains a difficult environment in which to raise capital. This has resulted in some advisory projects that launched in the summer not being completed by the end of the Period which includes a major UK hotel group and a leading brewery and pub group. Marechale continues to look for new and strategic funding partners alongside its traditional investor relationships.

The Board is working on a number of initiatives to create further value for shareholders over and above its core investment portfolio and corporate finance projects, including working with various potential businesses and individuals. The plan is to continue to develop Marechale’s strategic partnerships with the objective of enhancing shareholder value.

Marechale also uses its balance sheet to co-invest in its client companies, along with warrants and founder equity. Furthermore, the Board is able to announce a partial realisation of £109,000 for cash on two of the Company’s investments. Cash at bank at 31 October 2024 was £223,700.

Whist the current economic climate is difficult, Marechale Capital remains diligent and is convinced that there will be good advisory and investment opportunities in its core hospitality, renewable, clean energy and technology sectors over the short to medium term.

Mark Warde-Norbury

Chairman

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014

For further information please contact:

Marechale Capital

Mark Warde-Norbury / Patrick Booth-Clibborn

Tel: +44 (0)20 7628 5582

Cairn Financial Advisers LLP

Jo Turner / Sandy Jamieson

Tel: +44 (0)20 7213 0880

Income Statement (unaudited)
6 months ended 31 October20242023
£
Revenue148,500320,603
Cost of sales(45,032)(226,790)
Gross profit 103,46893,813
Administrative expenses(241,953)(249,235)
Operating loss(138,485)(155,421)
Exceptional credit10,316-
Loss on disposal of investments(49,837)
Interest paid(255)(382)
(Loss)/profit before tax(178,261)(155,803)
Taxation--
(Loss)/profit after tax(178,261)(155,803)
(Loss)/profit per share
(Pence)(Pence)
- Basic(0.17)(0.15)
- Diluted(0.17)(0.14)
Balance Sheet (unaudited)
As at31 October31 October
20242023
Current assets
Available for sale investments2,939,6602,863,227
Trading investments49,953130,076
Trade and other receivables52,85637,219
Cash and cash equivalents223,712398,229
3,266,1813,428,751
Current liabilities
Trade and other payablesPAYEBounce-back Loan(54,338)(10,806)(10,000)(51,278)(9,847)(10,000)
Total current liabilities(75,144)(70,765)
Net current assets3,191,0373,357,986
Bounce-back Loan – long-term(7,500)(17,500)
Net assets3,183,5373,340,486
Equity
Capital and reserves attributable to equity shareholders
Share capitalShare premium847,530481,290847,530481,290
Reserve for own shares(50,254)(50,254)
Retained profits/ (losses)1,739,3971944,842
Reserve for share based payments165,574117,078
3,183,5373,340,486
Cash Flow Statement (unaudited)
6 months ended31 October31 October
20242023
££
Net cash from operating activities
Loss after tax (178,261)(155,803)
Reverse exceptional credits(10,316)-
Loss of disposal of investments49,837
Provision for share based paymentsReverse interest paid15,40625533,091381
Operating cash flows before movements in working capital(123,079)(122,331)
Movement in working capital
(Increase)/ decrease in receivables(7,950)38,714
Increase/ (decrease) in payables3,108(30,795)
Net movement in working capital(4,842)7,919
Operating cash out-flow(127,921)(114,412)
Investment activities
Expenditure on available for sale investments-572
Proceeds from sale of investments and options108,692-
Cash flow from investing activities108,692(572)
FinancingShare CapitalBounce-back Loan repaymentsInterest paidNet financing-(5,000)(255)(5,255)235,800(5,000)(381)230,419
Net (decrease)/ increase in cash and cash equivalents(24,484)115,435
Cash and cash equivalents at start of the period248,196282,794
Cash and cash equivalents at end of the period223,712398,229
(Decrease)/ increase in cash and cash equivalents(24,484)115,435

This financial information has been prepared in accordance with IFRS and International Financial Reporting Interpretations Committee ('IFRIC') interpretations adopted by the European Union, and with those parts of the Companies Act 2006 applicable to companies reporting under IFRS, with the prior period being reported on the same basis.



Date   Source Headline
20th Jan 20163:14 pmRNSDirectorate Change
19th Jan 20161:11 pmRNSStmnt re Share Price Movement
17th Dec 20157:00 amRNSHalf Yearly Report
19th Nov 20155:30 pmRNSNorthfield UK Solar Update
6th Nov 20151:24 pmRNSNorthfield UK Solar Update
17th Sep 20154:14 pmRNSResult of AGM
26th Aug 20153:23 pmRNSPosting of Annual Report and Notice of AGM
26th Aug 20158:12 amRNSNorthfield UK Solar Update
24th Aug 20154:04 pmRNSHolding(s) in Company
21st Aug 201511:03 amRNSShare Price Movement
28th Jul 20151:41 pmRNSFinal Results
3rd Jun 20154:30 pmRNSHolding(s) in Company
5th May 20155:03 pmRNSDirector/PDMR Shareholding
2nd Apr 20159:45 amRNSHolding(s) in Company
31st Mar 20153:16 pmRNSHolding(s) in Company
20th Feb 201512:52 pmRNSDirector/PDMR Shareholding
3rd Feb 20152:52 pmRNSDirector/PDMR Shareholding
2nd Feb 20155:24 pmRNSDirector/PDMR Shareholding
9th Dec 20144:41 pmRNSHolding(s) in Company
24th Sep 20142:28 pmRNSResult of AGM
27th Aug 20148:25 amRNSPosting of Annual Results and Notice of AGM
11th Aug 201410:13 amRNSHolding(s) in Company
25th Jul 201410:13 amRNSFinal Results
11th Apr 20142:33 pmRNSHolding(s) in Company
11th Apr 20148:55 amRNSDirector/PDMR Shareholding
8th Apr 20145:20 pmRNSHolding(s) in Company
18th Mar 20143:12 pmRNSHolding(s) in Company
17th Feb 20142:26 pmRNSCompletes Solar Funding Round
18th Dec 20132:37 pmRNSDirector/PDMR Shareholding
17th Dec 20137:00 amRNSInterim Results
9th Dec 20135:06 pmRNSHolding(s) in Company
17th Oct 201311:26 amRNSHolding(s) in Company
10th Oct 20132:42 pmRNSDirector/PDMR Shareholding
18th Sep 20132:12 pmRNSResult of AGM
3rd Sep 20131:45 pmRNSDirector/PDMR Shareholding
8th Aug 201311:34 amRNSPosting of Results & Notice of AGM
1st Aug 20132:13 pmRNSDirector/PDMR Shareholding
25th Jul 20134:41 pmRNSHolding(s) in Company
25th Jul 20137:00 amRNSFinal Results
26th Jun 20137:00 amRNSBoard change
3rd Apr 201310:58 amRNSDirector/PDMR Shareholding
30th Jan 20135:47 pmRNSHolding(s) in Company
13th Dec 20127:00 amRNSHalf Yearly Report
25th Sep 20123:53 pmRNSResult of AGM
17th Sep 20124:26 pmRNSPosting of Annual Report & Notice of AGM
4th Sep 20125:49 pmRNSHolding(s) in Company
4th Sep 20125:48 pmRNSHolding(s) in Company
15th Aug 20124:00 pmRNSFinal Results
18th Apr 201212:06 pmRNSDirector/PDMR Shareholding
22nd Mar 20122:53 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.